In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape.
暂无分享,去创建一个
Luis M Liz-Marzán | Marilena Hadjidemetriou | Kostas Kostarelos | Ana Sánchez-Iglesias | L. Liz‐Marzán | Kostas Kostarelos | A. Sánchez-Iglesias | Rafaela García-Álvarez | Marilena Hadjidemetriou | Rafaela García-Álvarez
[1] Roberto Cingolani,et al. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. , 2010, ACS nano.
[2] V. Puntes,et al. Size-Dependent Protein-Nanoparticle Interactions in Citrate-Stabilized Gold Nanoparticles: The Emergence of the Protein Corona. , 2017, Bioconjugate chemistry.
[3] Philippe Guyot-Sionnest,et al. Mechanism of silver(I)-assisted growth of gold nanorods and bipyramids. , 2005, The journal of physical chemistry. B.
[4] J. Hillier,et al. A study of the nucleation and growth processes in the synthesis of colloidal gold , 1951 .
[5] C. Trachsel,et al. Human Blood Plasma Proteins: Structure and Function , 2008 .
[6] Tuan Vo-Dinh,et al. Gold nanostars: surfactant-free synthesis, 3D modelling, and two-photon photoluminescence imaging , 2012, Nanotechnology.
[7] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[8] Parag Aggarwal,et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[9] Emily R Evans,et al. Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions , 2016, Nanoscale Research Letters.
[10] P. Jain,et al. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. , 2006, The journal of physical chemistry. B.
[11] S. Parasuraman,et al. Blood sample collection in small laboratory animals , 2010, Journal of pharmacology & pharmacotherapeutics.
[12] H. Ghandehari,et al. Differential Protein Adsorption and Cellular Uptake of Silica Nanoparticles Based on Size and Porosity. , 2016, ACS applied materials & interfaces.
[13] Giulio Caracciolo,et al. Surface chemistry and serum type both determine the nanoparticle-protein corona. , 2015, Journal of proteomics.
[14] K. Soo,et al. Protein Corona around Gold Nanorods as a Drug Carrier for Multimodal Cancer Therapy. , 2017, ACS biomaterials science & engineering.
[15] Murali M. Yallapu,et al. Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles. , 2015, Biomaterials.
[16] K. Hamad-Schifferli,et al. Protein coronas on gold nanorods passivated with amphiphilic ligands affect cytotoxicity and cellular response to penicillin/streptomycin. , 2014, ACS nano.
[17] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[18] Chad A Mirkin,et al. Gold nanoparticles for biology and medicine. , 2010, Angewandte Chemie.
[19] Mostafa A. El-Sayed,et al. Preparation and Growth Mechanism of Gold Nanorods (NRs) Using Seed-Mediated Growth Method , 2003 .
[20] M. Mahmoudi,et al. Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.
[21] Anil K Patri,et al. Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[22] Raehyun Kim,et al. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum. , 2016, The international journal of biochemistry & cell biology.
[23] M. El-Sayed,et al. Why gold nanoparticles are more precious than pretty gold: noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes. , 2006, Chemical Society reviews.
[24] Morteza Mahmoudi,et al. Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. , 2017, Trends in biotechnology.
[25] Marilena Hadjidemetriou,et al. Nanomedicine: Evolution of the nanoparticle corona. , 2017, Nature nanotechnology.
[26] Katharina Landfester,et al. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. , 2016, Nature nanotechnology.
[27] W. Kreyling,et al. Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles , 2013, Nanotechnology.
[28] S. Stolte,et al. The nanoparticle biomolecule corona: lessons learned - challenge accepted? , 2015, Chemical Society reviews.
[29] Alaaldin M. Alkilany,et al. Protein corona: Opportunities and challenges. , 2016, The international journal of biochemistry & cell biology.
[30] Vipul Bansal,et al. Size, shape and surface chemistry of nano-gold dictate its cellular interactions, uptake and toxicity , 2016 .
[31] R. Müller,et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.
[32] W. Parak,et al. Gold-Based Nanomaterials for Applications in Nanomedicine. , 2016, Topics in current chemistry.
[33] L. Liz‐Marzán,et al. A "Tips and Tricks" Practical Guide to the Synthesis of Gold Nanorods. , 2015, The journal of physical chemistry letters.
[34] Xiue Jiang,et al. Impact of shape and pore size of mesoporous silica nanoparticles on serum protein adsorption and RBCs hemolysis. , 2014, ACS applied materials & interfaces.
[35] Luca Digiacomo,et al. Personalized liposome-protein corona in the blood of breast, gastric and pancreatic cancer patients. , 2016, The international journal of biochemistry & cell biology.
[36] L. Liz‐Marzán,et al. Reshaping and LSPR tuning of Au nanostars in the presence of CTAB , 2011 .
[37] G. Caracciolo,et al. Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells. , 2017, Colloids and surfaces. B, Biointerfaces.
[38] Dongyu Chen,et al. Plasma protein adsorption and biological identity of systemically administered nanoparticles. , 2017, Nanomedicine.
[39] Marilena Hadjidemetriou,et al. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles. , 2015, ACS nano.
[40] Darren J. Martin,et al. Differential plasma protein binding to metal oxide nanoparticles , 2009, Nanotechnology.
[41] K. Landfester,et al. Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake. , 2016, Nanoscale.
[42] Marco P Monopoli,et al. Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.
[43] E. Fisher,et al. The origins and uses of mouse outbred stocks , 2005, Nature Genetics.
[44] C. Trachsel,et al. Human Blood Plasma Proteins , 2008 .
[45] Marilena Hadjidemetriou,et al. Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles. , 2016, Nanoscale.
[46] Samir Mitragotri,et al. A Review of Clinical Translation of Inorganic Nanoparticles , 2015, The AAPS Journal.
[47] A. De Vizcaya-Ruiz,et al. A comparison of the human and mouse protein corona profiles of functionalized SiO2 nanocarriers. , 2017, Nanoscale.
[48] Giulio Caracciolo,et al. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. , 2014, Nanoscale.
[49] Z. Chai,et al. Protein corona influences liver accumulation and hepatotoxicity of gold nanorods , 2016 .
[50] S. Muyldermans,et al. Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostars. , 2017, Biomaterials.
[51] L. Liz‐Marzán,et al. Stabilization and Encapsulation of Gold Nanostars Mediated by Dithiols. , 2015, Small.